Emerging Evidence That the Ban on Asbestos Use is Reducing the Occurrence of Pleural Mesothelioma in Sweden

Overview

Journal Scand J Public Health

Publisher Sage Publications

Specialty Public Health

Date 2015 Jul 22

PMID 26194352

Citations 19

Authors

Bengt Jarvholm

Alex Burdorf

Affiliations

Soon will be listed here.

Abstract

Aims: Several countries have banned the use of asbestos. The future health impacts of previous use have been modeled but there are to our knowledge no convincing studies showing a decreased occurrence of asbestos-related diseases due to a ban. The aim of our study was to estimate the effects of the ban and other measures to decrease the use of asbestos in Sweden.

Methods: The effect was measured through comparing the incidence of pleural malignant mesothelioma in birth cohorts who started to work before and after the decrease in the use of asbestos, i.e. in mid-1970s. Cases were identified through the Swedish Cancer Registry and the analysis was restricted to persons born in Sweden.

Results: Men and women born 1955-79 had a decreased risk of malignant pleural mesothelioma compared to men and women born 1940-49 (RR 0.16, 95% CI 0.11-0.25; and RR 0.47, 95% CI 0.23-0.97 respectively). The decreased use of asbestos prevented each year about 10 cases in men and two cases in women below the age of 57 years in 2012.

Conclusions: The ban and decreased use of asbestos in Sweden can be measured today in birth cohorts that started their working career after the decrease.

Citing Articles

Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990-2019.

Chen Z, Cai Y, Ou T, Zhou H, Li H, Wang Z J Cancer Res Clin Oncol. 2024; 150(5):282.

PMID: 38806867 PMC: 11133219. DOI: 10.1007/s00432-024-05802-6.

Changing smoking habits and the occurrence of lung cancer in Sweden-a population analysis.

Jarvholm B, Hedman L, Landstrom M, Liv P, Burdorf A, Toren K Eur J Public Health. 2024; 34(3):566-571.

PMID: 38519451 PMC: 11161152. DOI: 10.1093/eurpub/ckae050.

Asbestos and disease - a public health success story?.

Jarvholm B, Burdorf A Scand J Work Environ Health. 2024; 50(2):53-60.

PMID: 38323897 PMC: 10924740. DOI: 10.5271/sjweh.4146.

SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.

Xu M, Tu Y, Bi W, Lundberg M, Klooster I, Fletcher J Br J Cancer. 2023; 129(3):531-540.

PMID: 37369845 PMC: 10403575. DOI: 10.1038/s41416-023-02330-x.

Global, regional, and national trends in mesothelioma burden from 1990 to 2019 and the predictions for the next two decades.

Zhu W, Liu J, Li Y, Shi Z, Wei S SSM Popul Health. 2023; 23:101441.

PMID: 37334331 PMC: 10272494. DOI: 10.1016/j.ssmph.2023.101441.

References

McCormack V, Peto J, Byrnes G, Straif K, Boffetta P . Estimating the asbestos-related lung cancer burden from mesothelioma mortality. Br J Cancer. 2012; 106(3):575-84. PMC: 3273352. DOI: 10.1038/bjc.2011.563. View

Burdorf A, Jarvholm B, Englund A . Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer. 2004; 113(2):298-301. DOI: 10.1002/ijc.20552. View

Jarvholm B, Englund A . The impact of asbestos exposure in Swedish construction workers. Am J Ind Med. 2013; 57(1):49-55. DOI: 10.1002/ajim.22264. View

LaDou J, Castleman B, Frank A, Gochfeld M, Greenberg M, Huff J . The case for a global ban on asbestos. Environ Health Perspect. 2010; 118(7):897-901. PMC: 2920906. DOI: 10.1289/ehp.1002285. View

Peto J, SEIDMAN H, SELIKOFF I . Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer. 1982; 45(1):124-35. PMC: 2010947. DOI: 10.1038/bjc.1982.15. View

Delgermaa V, Takahashi K, Park E, Le G, Hara T, Sorahan T . Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011; 89(10):716-24, 724A-724C. PMC: 3209980. DOI: 10.2471/BLT.11.086678. View

Kameda T, Takahashi K, Kim R, Jiang Y, Movahed M, Park E . Asbestos: use, bans and disease burden in Europe. Bull World Health Organ. 2014; 92(11):790-7. PMC: 4221761. DOI: 10.2471/BLT.13.132118. View

Al-Delaimy W . The JPC-SE position statement on asbestos: a long-overdue appeal by epidemiologists to ban asbestos worldwide and end related global environmental injustice. Environ Health Perspect. 2013; 121(5):a144-5. PMC: 3673210. DOI: 10.1289/ehp.1306892. View

Darnton A, McElvenny D, Hodgson J . Estimating the number of asbestos-related lung cancer deaths in Great Britain from 1980 to 2000. Ann Occup Hyg. 2005; 50(1):29-38. DOI: 10.1093/annhyg/mei038. View

10.

Lin R, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T . Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007; 369(9564):844-849. DOI: 10.1016/S0140-6736(07)60412-7. View

11.

Nishikawa K, Takahashi K, Karjalainen A, Wen C, Furuya S, Hoshuyama T . Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment. Environ Health Perspect. 2008; 116(12):1675-80. PMC: 2599762. DOI: 10.1289/ehp.11272. View

12.

Jarvholm B, Englund A, Albin M . Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med. 1999; 56(2):110-3. PMC: 1757698. DOI: 10.1136/oem.56.2.110. View